Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 1, 2014, Pages 322-329

  Malin, Steven K ^a,b   Kirwan, John P ^a,b   Sia, Chang Ling ^c   González, Frank ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLUCOSE; MEMBRANE PROTEIN; P47PHOX PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN SYNTHESIS; ARTICLE; BODY MASS; CELL ISOLATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN-SECRETING CELLS; LEUKOCYTES, MONONUCLEAR; OBESITY; OXIDATIVE STRESS; POLYCYSTIC OVARY SYNDROME; THINNESS; YOUNG ADULT;

EID: 84892152567     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3177     Document Type: Article

References (40)

1. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095-1105.
2. Ciampelli M, Leoni F, Cucinelli F, et al. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab. 2005;90(3):1398-1406.
3. De Ugarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril. 2005;83(5):1454-1460.
4. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity andβ-cell function in human subjects: evidence for a hyperbolic function. Diabetes. 1993;42(11): 1663-1672.
5. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994;78(5):1052-1058.
6. Ciampelli M, Fulghesu AM, Cucinelli F, et al. Heterogeneity inβ-cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod. 1997; 12(9):1897-1901.
7. Ciampelli M, Fulghesu AM, Cucinelli F, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999;48(2):167-172.
8. Dunaif A, Finegood DT. β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81(3):942-947.
9. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS. Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulindependent diabetes mellitus. J Clin Invest. 1995;96(1):520-527.
10. De Fronzo RA, Abdul-Ghani MA. Preservation of β-cell function: the key to diabetes prevention. J Clin Endocrinol Metab. 2011; 96(8):2354-2366.
11. González F, Nair KS, Daniels JK, Basal E, Schimke JM, Blair HE. Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. J Clin Endocrinol Metab. 2012;97(8):2836-2843.
12. González F, Sia CL, Shepard MK, Rote NS, Minium J. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weightwomenwith polycystic ovary syndrome. Hum Reprod. 2012;27(12):3560-3568.
13. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: acommonendocrinopathy with distinct pathophysiologic features. Obstet Gynecol. 1983;147(1):90-101.
14. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):336-340.
15. Chanock SJ, el Benna J, Smith RM, Babior BM. The respiratory burst oxidase. J Biol Chem. 1994;269(40):24519-24522.
16. González F, Nair KS, Daniels JK, Basal E, Schimke JM, Blair HE. Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women. Am J Physiol Endocrinol Metab. 2012;302(3):E297-E306.
17. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ. Human aging is associated with altered TNF-α production during hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol Metab. 2001;281(6):E1137-E1143.
18. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50(1):113-116.
19. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6): 2001-2005.
20. Saadeh M, Ferrante TC, Kane A, Shirihai O, Corkey BE, Deeney JT. Reactive oxygen species stimulate insulin secretion in rat pancreatic islets: Studies using mono-oleoyl-glycerol. PLoS ONE. 2012;7(1):e30200-e30200.
21. El-Assaad W, Buteau J, Peyot ML, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death. Endocrinology. 2003;144(9):4154-4163.
22. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-1470.
23. Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Med. 1994;11(3): 286-292.
24. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA. β-Cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia. 2004; 47(1):31-39.
25. Clasey JL, Bouchard C, Teates D, et al. The use of anthropometric and dual-energy x-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obesity. 1999;7:256-264.
26. Thusu K, Abdel-Rahman E, Dandona P. Measurement of reactive oxygen species in whole blood and mononuclear cells using chemiluminescence. Methods Mol Biol. 1998;108:57-62.
27. Aljada A, Ghanim H, Dandona P. Translocation of p47phox and activation of NADPH oxidase in mononuclear cells. Methods Mol Biol. 2002;196:99-103.
28. Tosi F, Negri C, Perrone F, et al. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2012;97(5):1712-1719.
29. Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am. 1999;28(2):361-378.
30. González F, Sia CL, Shepard MK, Rote NS, Minium J. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weightwomenwith polycystic ovary syndrome. J Clin Endocrinol Metab. 2012;97(11):4071-4079.
31. González F, Minium J, Rote NS, Kirwan JP. Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 90(9):5336-5342.
32. Wong DH, Villanueva JA, Cress AB, Sokalska A, Ortega I, Duleba AJ. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells. Fertil Steril. 2011;96(5):1252-1258.
33. Spaczynski RZ, Arici A, Duleba AJ. Tumor necrosis factor-α stimulates proliferation of rat ovarian theca-interstitial cells. Biol Reprod. 1999;61(4):993-998.
34. Sokalska A, Piotrowski PC, Rzepczynska IJ, Cress A, Duleba AJ. Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability. J Clin Endocrinol Metab. 2010;95(12):5390-5394.
35. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care. 1998;21(9):1529-1533.
36. Evans JL Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23(5):599-622.
37. Robertson RP. β-Cell deterioration during diabetes: what's in the gun? Trends Endocrinol Metab. 2009;20(8):388-393.
38. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007;56(9):2356-2370.
39. Ceriello A, Testa R. Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S232-S236.
40. Tang C, Han P, Oprescu AI, et al. Evidence for a role of superoxide generation in glucose-induced β-Cell dysfunction in vivo. Diabetes. 2007;56(11):2722-2731.